Your browser doesn't support javascript.
Outcome of Myeloma Patients with COVID-19 on Active Lenalidomide-Based Therapy: Does Lenalidomide Protect From Severe COVID-19?
Tailor, Imran K; Alshehry, Nawal F; Zaidi, Syed Z; Marei, Mohammed A; Motabi, Ibraheem H; Alfayez, Mansour; Altaf, Syed Y.
  • Tailor IK; Department of Adult Hematology and Bone Marrow Transplantation, King Fahad Medical City, Riyadh, Saudi Arabia.
  • Alshehry NF; Department of Adult Hematology and Bone Marrow Transplantation, King Fahad Medical City, Riyadh, Saudi Arabia.
  • Zaidi SZ; Department of Adult Hematology and Bone Marrow Transplantation, King Fahad Medical City, Riyadh, Saudi Arabia.
  • Marei MA; Department of Adult Hematology and Bone Marrow Transplantation, King Fahad Medical City, Riyadh, Saudi Arabia.
  • Motabi IH; Department of Adult Hematology and Bone Marrow Transplantation, King Fahad Medical City, Riyadh, Saudi Arabia.
  • Alfayez M; Department of Adult Hematology and Bone Marrow Transplantation, King Fahad Medical City, Riyadh, Saudi Arabia.
  • Altaf SY; Department of Adult Hematology and Bone Marrow Transplantation, King Fahad Medical City, Riyadh, Saudi Arabia.
Hematol Oncol Stem Cell Ther ; 16(1): 88-90, 2023 01 12.
Article in English | MEDLINE | ID: covidwho-764643
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Multiple Myeloma Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Hematol Oncol Stem Cell Ther Journal subject: Hematology / Neoplasms Year: 2023 Document Type: Article Affiliation country: J.hemonc.2020.08.002

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Multiple Myeloma Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Hematol Oncol Stem Cell Ther Journal subject: Hematology / Neoplasms Year: 2023 Document Type: Article Affiliation country: J.hemonc.2020.08.002